Cited 29 time in
Caffeic acid and quercitrin purified from Houttuynia cordata inhibit DNA topoisomerase I activity
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jang, Seok-Young | - |
| dc.contributor.author | Bae, Jeen-Soo | - |
| dc.contributor.author | Lee, Yun Ho | - |
| dc.contributor.author | Oh, Kyeong Yeol | - |
| dc.contributor.author | Park, Ki-Hun | - |
| dc.contributor.author | Bae, Young-Seuk | - |
| dc.date.accessioned | 2022-12-27T03:54:36Z | - |
| dc.date.available | 2022-12-27T03:54:36Z | - |
| dc.date.issued | 2011 | - |
| dc.identifier.issn | 1478-6419 | - |
| dc.identifier.issn | 1478-6427 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/24790 | - |
| dc.description.abstract | A methanol extract of Houttuynia cordata showed an inhibitory effect on mammalian DNA topoisomerase I. Two topoisomerase I inhibitory compounds were purified and identified as caffeic acid and quercitrin. Caffeic acid and quercitrin inhibited the activity of topoisomerase I with IC50 values of about 0.15 and 0.05 mM, respectively. A concentration of 45 mu M caffeic acid caused 50% growth inhibition in human leukaemia U937 cells, but not on those of normal fibroblast NIH3T3 cells. However, quercitrin mysteriously stimulated proliferation of U937 and NIH3T3 cells. Caffeic acid-induced cell death was characterised with the cleavage of poly (ADP-ribose) polymerase and procaspase-3, indicating that this inhibitor triggered apoptosis. The apoptotic induction by caffeic acid was also confirmed using flow cytometry analysis. Because DNA topoisomerase I is an important target for tumour chemotherapy, the present study suggests that caffeic acid, but not quercitrin, may function by suppressing oncogenic disease through the inhibition of cellular topoisomerase I activity. | - |
| dc.format.extent | 10 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | TAYLOR & FRANCIS LTD | - |
| dc.title | Caffeic acid and quercitrin purified from Houttuynia cordata inhibit DNA topoisomerase I activity | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1080/14786410903339044 | - |
| dc.identifier.scopusid | 2-s2.0-79551664369 | - |
| dc.identifier.wosid | 000286894900004 | - |
| dc.identifier.bibliographicCitation | NATURAL PRODUCT RESEARCH, v.25, no.3, pp 222 - 231 | - |
| dc.citation.title | NATURAL PRODUCT RESEARCH | - |
| dc.citation.volume | 25 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 222 | - |
| dc.citation.endPage | 231 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Chemistry | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Applied | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
| dc.subject.keywordPlus | CAMPTOTHECIN | - |
| dc.subject.keywordPlus | INTEGRASE | - |
| dc.subject.keywordPlus | CLEAVAGE | - |
| dc.subject.keywordPlus | VIRUS | - |
| dc.subject.keywordPlus | MOUSE | - |
| dc.subject.keywordPlus | DEATH | - |
| dc.subject.keywordAuthor | Houttuynia cordata | - |
| dc.subject.keywordAuthor | DNA topoisomerase I inhibitor | - |
| dc.subject.keywordAuthor | caffeic acid | - |
| dc.subject.keywordAuthor | quercitrin | - |
| dc.subject.keywordAuthor | human leukaemia cells | - |
| dc.subject.keywordAuthor | anti-tumour drug | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
